The US pharma giant, already pulling in huge profits from its COVID vaccine, is estimated to reap billions from sales of its experimental therapy, Paxlovid.
Brisbane Times – Business
The US pharma giant, already pulling in huge profits from its COVID vaccine, is estimated to reap billions from sales of its experimental therapy, Paxlovid.
Brisbane Times – Business